ArticlePediatric research2026
Short outcomes of donor milk and mother's own milk for preterm infants.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhen MOM is unavailable, Donor Human Milk (DHM) is proposed, however, there is still insufficient evidence to determine whether DHM has similar benefits to MOM. This study aims to determine the relationship between DHM intake and MOM with short-term outcomes in preterm infants, hospitalized in Neonatal Intensive Care Units (NICU).
methodsThis prospective cohort study was conducted in October 2023 to December 2024 on preterm infants aged less than 32 weeks, who were hospitalized in NICU of selected hospitals of Isfahan University of Medical Sciences, Iran. Participants consisted of 392 preterm infants who were assigned into two groups receiving DHM > 70% (n = 140) and MOM > 70% (n = 252). Primary and secondary outcomes were monitored and recorded by the researcher during the preterm infant's hospitalization in the intensive care unit until discharge.
resultsResults showed that the incidence of Metabolic Bone Disease (MBD) was not significantly different in the two groups (OR = 1.31, 95% CI: 0.70-2.47, p = 0.395). Osteopenia of prematurity (OR = 0.79, 95% CI: 0.27-2.33, p = 0.665), and Necrotizing Enterocolitis (NEC) (OR = 0.88, 95% CI: 0.35-2.20, p = 0.789), both showing no significant differences. Positive blood culture (OR = 0.54, 95% CI: 0.22-1.33, p = 0.179), indicating a non-significant lower risk in the DHM group. In contrast, Bronchopulmonary Dysplasia (BPD) showed a significantly higher risk in the DHM group (OR = 2.01, 95% CI: 1.22-3.29, p = 0.006). Total Parenteral Nutrition (TPN) duration, achieving feeding volume of 120 ml/kg/days and full interal feeding were significantly shorter in the DHM group (p < 0.001).
conclusionsThese results identify that BPD was significantly more common in the DHM group than in the MOM group. Holder pasteurization may lead to the removal of anti-inflammatory factors in MOM and increase the incidence of BPD in preterm infants receiving DHM. IMPACT: The popularity of using DHM as standard nutritional care in neonatal intensive care units is increasing To our knowledge, this is one of the few cohort studies exploring short-term outcomes of preterm infants in MOM and DHM fed groups until discharge Initiation, duration, and volume of feeding of preterm infants with DHM are one of the strengths points of this study, which provides valuable clinical application in the nutrition of preterm infants There is a need for the development of public policy to increase both the access to DHM and awareness regarding its beneficial effects, especially amongst populations with low breastfeeding rates.
Indexed as
Identifiers
40527952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.